Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: J Sex Res. 2015 Nov 18;53(7):805–815. doi: 10.1080/00224499.2015.1092018

Table 4.

Single Outcomes By Partner Types

Variable Steady (N=962) OR (95% C.I.) Interaction Term Added OR (95% C.I.) Casual (N=587) OR (95% C.I.)
Age 0.99 (0.97, 1.00) 0.99 (0.97, 1.00)+ 1.00 (0.98, 1.01)
Gender (female) 0.82 (0.63, 1.08) 1.07 (0.68, 1.67)
Stable Home
Relationship statusa
    Partnered and living together 0.54 (0.37, 0.80)** 0.54 (0.37,0.80)** 1.71 (1.10, 2.66)*
    Partnered and not living together 0.19 (0.12, 0.29)*** 0.17 (0.11, 0.28)*** 1.34 (0.72, 2.48)
More than one partner 1.24 (0.84, 1.82) 1.19 (0.79, 1.77) 0.96 (0.64, 1.43)
Self/sex partner drug useb
    Only participant used drugs 1.03 (0.56, 1.91) 0.60 (0.30, 1.17) 1.30 (0.65, 2.57)
    Only partner used drugs 0.54 (0.34, 0.84)** 1.12 (0.62, 2.01) 0.76 (0.50, 1.16)
    Participant and partner used drugs 0.70 (0.42, 1.16) 0.83 (0.46, 1.50) 0.45 (0.28, 0.74)**
Gender × self/sex partner drug use
    Only participant used drugs * Female 2.84 (0.95, 8.48)+
    Only partner used drugs 0.23 (0.10, 0.54)**
    Participant and partner used drugs * Female 0.71 (0.28, 1.78)
Condom use self-efficacyc 1.07 (1.04, 1.11)*** 1.07 (1.04, 1.11)*** 1.10 (1.06, 1.14)***
+

p < .10

*

p < .05

**

p < 0.1

***

p < .001

a

Reference category is Not partnered

b

Reference category is Neither used drugs

c

Interaction term with Self/sex partner drug use; interaction term with Condom use self-efficacy was not significant for any group